058820 CMG제약
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 1,460억원 (2026-06-30 기준)
- 첫 등장: 2026-06-29 (누적 1일)
- 태그: 매크로/바이오헬스 · 매크로/소재화학 · 구강용해필름 · 개량신약 · 항암제 · CDMO · 세포치료제
- 네이버 금융: 🔗
기업개요
- 동사는 2001년 코스닥시장에 상장한 차바이오그룹 핵심 계열사로, 2008년 쎌라트팜코리아를 흡수합병하여 의약품 생산 및 판매 사업을 본격화함.
- 의약품과 건강기능식품의 연구, 개발, 생산 및 판매를 주사업으로 영위하며, 핵심 기술인 STARFILM Technology 기반의 구강용해필름(ODF) 개발과 생산에 집중하고 있음.
- 항암제, 안티에이징, 안과, 건강기능식품 등 성장성 높은 신사업으로 포트폴리오를 확대하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 671 | 662 | 🔵 -1.34% | — | ×1.1 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | -0.0 | +0.0 | -0.2 | +0.1 |
| 2026-08-13 | 609 | 671 | 🔴 +10.18% | — | ×4.2 | 🟢 외인 | +3.5억 | +3.5 | +0.0 | +0.0 | +0.0 | -3.3 | -0.1 |
| 2026-08-12 | 717 | 609 | 🔵 -15.06% | — | ×3.8 | 🔻 개인 | -2.4억 | -2.4 | +0.0 | +0.0 | +0.0 | +2.4 | +0.1 |
| 2026-08-11 | 704 | 717 | 🔴 +1.85% | — | ×1.7 | 🟢 외인 | +2.6억 | +2.6 | +0.0 | -0.0 | +0.0 | -2.6 | +0.0 |
| 2026-08-10 | 715 | 704 | 🔵 -1.54% | — | ×1.8 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | +0.0 | +0.0 | -1.6 | +0.1 |
| 2026-08-07 | 710 | 715 | 🔴 +0.70% | — | ×1.2 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | -0.3 | +0.0 | -0.2 | +0.1 |
| 2026-08-06 | 739 | 710 | 🔵 -3.92% | — | ×1.2 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | -0.6 | +0.0 | -0.2 | +0.1 |
| 2026-08-05 | 746 | 739 | 🔵 -0.94% | — | ×0.6 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | -0.1 | +0.0 | +0.4 | +0.0 |
| 2026-08-04 | 709 | 746 | 🔴 +5.22% | — | ×0.9 | 🟢 외인 | +1.1억 | +1.1 | +0.0 | -0.4 | +0.0 | -0.7 | -0.0 |
| 2026-08-03 | 730 | 709 | 🔵 -2.88% | — | ×1.1 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | -0.4 | +0.0 | -0.3 | -0.0 |
| 2026-07-31 | 700 | 730 | 🔴 +4.29% | — | ×1.5 | 🟡 금투 | +1.1억 | +1.1 | +0.0 | +1.6 | +0.0 | -2.7 | +0.0 |
| 2026-07-30 | 695 | 700 | 🔴 +0.72% | — | ×1.7 | 🟢 외인 | +2.6억 | +2.6 | +0.0 | -0.6 | +0.0 | -1.9 | -0.0 |
| 2026-07-29 | 730 | 695 | 🔵 -4.79% | — | ×1.8 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | +0.7 | +0.0 | -2.1 | +0.1 |
| 2026-07-28 | 800 | 730 | 🔵 -8.75% | — | ×0.9 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.0 | -0.0 |
| 2026-07-27 | 810 | 800 | 🔵 -1.23% | — | ×1.0 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | -0.2 | +0.0 | +0.5 | -0.0 |
| 2026-07-24 | 795 | 810 | 🔴 +1.89% | — | ×0.9 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.2 | +0.0 | -0.7 | -0.0 |
| 2026-07-22 | 799 | 785 | 🔵 -1.75% | — | ×1.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | -0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-21 | 801 | 799 | 🔵 -0.25% | — | ×1.4 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | +0.0 | +0.0 | -0.9 | +0.0 |
| 2026-07-20 | 839 | 801 | 🔵 -4.53% | — | ×1.1 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-16 | 861 | 839 | 🔵 -2.56% | — | ×0.5 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.0 | +0.4 | +0.0 |
| 2026-07-15 | 842 | 861 | 🔴 +2.26% | — | ×0.8 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.0 | +0.0 | -0.7 | +0.0 |
| 2026-07-14 | 862 | 842 | 🔵 -2.32% | — | ×1.6 | 🔻 개인 | -0.7억 | -0.7 | +0.0 | +0.0 | +0.0 | +0.7 | +0.0 |
| 2026-07-13 | 915 | 862 | 🔵 -5.79% | — | ×0.9 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | +0.0 | -0.5 | +0.0 |
| 2026-07-10 | 872 | 915 | 🔴 +4.93% | — | ×0.4 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | -0.0 | +0.0 | -0.9 | +0.1 |
| 2026-07-09 | 898 | 872 | 🔵 -2.90% | — | ×0.7 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.1 | +0.0 | +0.2 | +0.0 |
| 2026-07-08 | 928 | 898 | 🔵 -3.23% | — | ×0.6 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-07 | 971 | 928 | 🔵 -4.43% | — | ×0.6 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | -0.0 | +0.0 | +1.0 | +0.0 |
| 2026-07-06 | 942 | 971 | 🔴 +3.08% | — | ×0.4 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-03 | 928 | 942 | 🔴 +1.51% | — | ×0.4 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | -0.0 | +0.0 | -0.9 | -0.0 |
| 2026-07-02 | 986 | 928 | 🔵 -5.88% | — | ×0.6 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.0 | +0.9 | -0.1 |
| 2026-07-01 | 986 | 986 | ⚪ +0.00% | — | ×0.6 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | -0.0 | +0.0 | +0.4 | -0.0 |
| 2026-06-30 | 1,015 | 986 | 🔵 -2.86% | — | ×1.1 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | -0.0 | -0.0 | +0.9 | +0.2 |
| 2026-06-29 | 870 | 1,015 | 🔴 +16.67% | — | ×2.1 | 🟢 외인 | +3.0억 | +3.0 | +0.0 | -0.0 | +0.0 | -2.9 | -0.1 |
| 2026-06-26 | 906 | 870 | 🔵 -3.97% | — | ×2.2 | 🟢 외인 | +2.3억 | +2.3 | +0.0 | +0.0 | +0.0 | -2.3 | +0.0 |
| 2026-06-25 | 931 | 906 | 🔵 -2.69% | — | ×1.7 | 🟢 외인 | +0.8억 | +0.7 | +0.0 | -0.1 | +0.1 | -0.8 | +0.1 |
| 2026-06-24 | 950 | 931 | 🔵 -2.00% | — | ×1.7 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | +0.0 | +0.0 | -0.9 | +0.0 |
| 2026-06-23 | 1,001 | 950 | 🔵 -5.09% | — | ×1.5 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.6 | +0.0 | |
| 2026-06-22 | 1,007 | 1,001 | 🔵 -0.60% | — | ×3.2 | 🟢 외인 | +1.5억 | +1.5 | +0.0 | +0.0 | -1.3 | -0.2 | |
| 2026-06-19 | 1,070 | 1,007 | 🔵 -5.89% | — | ×1.8 | 🔻 개인 | -1.2억 | -1.2 | +0.0 | +0.0 | +1.1 | +0.1 | |
| 2026-06-18 | 1,139 | 1,070 | 🔵 -6.06% | — | ×0.7 | 🔻 개인 | -1.4억 | -1.4 | +0.0 | -0.1 | +1.5 | +0.0 | |
| 2026-06-17 | 1,111 | 1,139 | 🔴 +2.52% | — | ×0.6 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.1 | -0.8 | +0.0 | |
| 2026-06-16 | 1,122 | 1,111 | 🔵 -0.98% | — | ×0.4 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | -0.0 | +0.0 | -0.0 | |
| 2026-06-15 | 1,122 | 1,122 | ⚪ +0.00% | — | ×0.4 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | +0.0 | +1.0 | +0.1 | |
| 2026-06-12 | 1,100 | 1,122 | 🔴 +2.00% | — | ×0.3 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | -0.0 | +0.2 | +0.0 | |
| 2026-06-11 | 1,070 | 1,100 | 🔴 +2.80% | — | ×0.5 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | -0.0 | |
| 2026-06-10 | 1,087 | 1,070 | 🔵 -1.56% | — | ×0.3 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | -0.0 | -0.1 | -0.1 | |
| 2026-06-09 | 1,045 | 1,087 | 🔴 +4.02% | — | ×0.8 | 🟢 외인 | +1.6억 | +1.6 | +0.0 | +0.0 | -1.6 | +0.0 | |
| 2026-06-08 | 1,134 | 1,045 | 🔵 -7.85% | — | ×1.2 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | -0.0 | -0.8 | +0.1 | |
| 2026-06-05 | 1,152 | 1,134 | 🔵 -1.56% | — | ×0.4 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | -0.5 | +0.1 | |
| 2026-06-04 | 1,175 | 1,152 | 🔵 -1.96% | — | ×0.8 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.0 | +0.5 | +0.1 | |
| 2026-06-02 | 1,190 | 1,175 | 🔵 -1.26% | — | ×0.7 | 🟢 외인 | +1.2억 | +1.2 | +0.0 | -0.1 | -1.1 | -0.1 | |
| 2026-06-01 | 1,236 | 1,190 | 🔵 -3.72% | — | ×1.1 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | -0.1 | +0.3 | -0.0 | |
| 2026-05-29 | 1,276 | 1,236 | 🔵 -3.13% | — | ×1.5 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | -0.0 | -0.2 | +0.0 | |
| 2026-05-28 | 1,300 | 1,276 | 🔵 -1.85% | — | ×0.8 | 🟢 외인 | +2.0억 | +2.0 | +0.0 | +0.1 | -2.1 | +0.0 | |
| 2026-05-27 | 1,370 | 1,300 | 🔵 -5.11% | — | ×1.4 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | +0.0 | -1.4 | -0.1 | |
| 2026-05-26 | 1,445 | 1,370 | 🔵 -5.19% | — | ×1.0 | 🔻 개인 | -4.6억 | -4.6 | +0.0 | -0.0 | +4.8 | -0.1 | |
| 2026-05-22 | 1,358 | 1,445 | 🔴 +6.41% | — | ×1.0 | 🟢 외인 | +5.8억 | +5.8 | +0.0 | -0.0 | -5.5 | -0.4 |
일자별 사유 (최신 위)
2026-08-13
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -511억)
- 매크로 원인: 임상 모멘텀(전립선암 1상, 인보사 美임상)과 반기실적 발표 겹쳐 바이오 전반 강세 (보통)
2026-06-29
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +305억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)